1. Expression of human cathelicidin peptide LL‐37 in inflammatory bowel disease. (28th September 2017) Authors: Kusaka, S.; Nishida, A.; Takahashi, K.; Bamba, S.; Yasui, H.; Kawahara, M.; Inatomi, O.; Sugimoto, M.; Andoh, A. Journal: Clinical and experimental immunology Issue: Volume 191:Number 1(2018:Jan.) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Letter: a potassium‐competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection‐induced artificial ulcers after treatment of gastric neoplasms. Issue 5 (4th August 2017) Authors: Ban, H.; Sugimoto, M.; Otsuka, T.; Murata, M.; Nakata, T.; Hasegawa, H.; Fukuda, M.; Inatomi, O.; Bamba, S.; Kushima, R.; Andoh, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 5(2017) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Letter: a potassium‐competitive acid blocker vs a proton pump inhibitor for healing endoscopic submucosal dissection‐induced artificial ulcers after treatment of gastric neoplasms. Issue 5 (September 2017) Authors: Ban, H.; Sugimoto, M.; Otsuka, T.; Murata, M.; Nakata, T.; Hasegawa, H.; Fukuda, M.; Inatomi, O.; Bamba, S.; Kushima, R.; Andoh, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 46:Issue 5(2017) Page Start: 564 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Letter: CYP3A4/5 genotype status and outcome of vonoprazan‐containing Helicobacter pylori eradication therapy in Japan. Issue 7 (3rd March 2017) Authors: Sugimoto, M.; Ban, H.; Hira, D.; Kamiya, T.; Otsuka, T.; Inatomi, O.; Bamba, S.; Terada, T.; Andoh, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 7(2017) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Letter: CYP3A4/5 genotype status and outcome of vonoprazan‐containing Helicobacter pylori eradication therapy in Japan. Issue 7 (April 2017) Authors: Sugimoto, M.; Ban, H.; Hira, D.; Kamiya, T.; Otsuka, T.; Inatomi, O.; Bamba, S.; Terada, T.; Andoh, A. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 7(2017) Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗